Animal health boosts Henry Schein's top line; FDA sued by environmental groups over animal drugs;

> Health products and services provider Henry Schein ($HSIC) reported record results in the third quarter, driven largely by 18% revenue growth in its animal health unit. Release

> The Center for Food Safety, the Center for Biological Diversity and the Sierra Club have filed a lawsuit against the FDA alleging that it approved certain animal drugs for use in food production without fully examining their impact on people, animals or the environment. Release

> Bartlett Milling has recalled some horse feeds due to contamination with Rumensin, an additive that can cause health problems in horses. Release

> The World Organisation for Animal Health has published the Guide to Terrestrial Animal Health Surveillance, a handbook for countries implementing disease surveillance programs. Release

> South Africa's Imperial Logistics bought a major stake of Pharmed Pharmaceutical, a wholesaler of medical and veterinary products. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…